| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.86B | 32.86B | 26.69B | 24.22B | 18.54B | 13.57B |
| Gross Profit | 8.69B | 11.41B | 9.53B | 7.46B | 5.78B | 4.17B |
| EBITDA | 3.05B | 4.96B | 3.84B | 2.51B | 2.03B | 1.57B |
| Net Income | 1.18B | 1.84B | 1.70B | 1.39B | 1.15B | 892.41M |
Balance Sheet | ||||||
| Total Assets | 32.95B | 49.21B | 30.47B | 24.02B | 21.96B | 23.02B |
| Cash, Cash Equivalents and Short-Term Investments | 7.89B | 12.05B | 7.67B | 4.66B | 5.23B | 3.65B |
| Total Debt | 15.90B | 26.79B | 12.13B | 8.42B | 8.67B | 11.64B |
| Total Liabilities | 18.83B | 32.93B | 16.12B | 11.56B | 10.64B | 13.22B |
| Stockholders Equity | 13.53B | 15.62B | 13.78B | 12.27B | 11.09B | 9.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -8.72B | 185.31M | 73.83M | 3.78B | -8.16B |
| Operating Cash Flow | 0.00 | -8.54B | 435.30M | 452.64M | 4.36B | -7.31B |
| Investing Cash Flow | 0.00 | -604.88M | -1.37B | -376.36M | -427.07M | -1.64B |
| Financing Cash Flow | 0.00 | 13.12B | 1.94B | -554.26M | -3.13B | 9.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥11.67B | 13.47 | ― | 4.98% | 6.29% | 6.28% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥23.19B | 37.49 | ― | ― | -2.59% | 61.28% | |
60 Neutral | ¥68.10B | 11.44 | ― | 5.71% | 2.53% | 5.07% | |
59 Neutral | ¥14.35B | 6.14 | ― | 1.47% | 15.19% | -6.43% | |
57 Neutral | ¥63.11B | 9.28 | ― | 2.89% | 4.32% | 11.25% | |
52 Neutral | ¥41.59B | 21.48 | ― | 0.45% | 23.11% | 8.31% |